Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Hypertriglyceridemia

1-methyl-3-isobutylxanthine has been researched along with Hypertriglyceridemia in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Hypertriglyceridemia: A condition of elevated levels of TRIGLYCERIDES in the blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balbo, SL1
Ribeiro, RA1
Mendes, MC1
Lubaczeuski, C1
Maller, AC1
Carneiro, EM1
Bonfleur, ML1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Hypertriglyceridemia

ArticleYear
Vagotomy diminishes obesity in cafeteria rats by decreasing cholinergic potentiation of insulin release.
    Journal of physiology and biochemistry, 2016, Volume: 72, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; Adipose Tissue; Animals; Body Weight; Carbachol; Colforsin; Cyclic AMP;

2016